Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Uveitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT07634848
What this trial is testing

Ivarmacitinib for Refractory Behcet's Syndrome

Who this might be right for
Behcet's Syndrome
Liu Tian
Post-approval studies (Phase 4)UnknownNCT04150770
What this trial is testing

A Clinical Trial of Infliximab for Childhood Uveitis

Who this might be right for
UveitisInfliximab
Xiaomin Zhang 10
Testing effectiveness (Phase 2)Study completedNCT01564108
What this trial is testing

The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema

Who this might be right for
Uveitis Related Cystoid Macular EdemaSteroid-induced Glaucoma - Borderline
Moorfields Eye Hospital NHS Foundation Trust 10
Post-approval studies (Phase 4)Not Yet RecruitingNCT05105347
What this trial is testing

Efficacy and Safety of Adalimumab Plus Medium Dose Oral Glucocorticosteroid for Refractory Behçet's Uveitis

Who this might be right for
Uveitis
Peking Union Medical College Hospital 130
Testing effectiveness (Phase 2)Ended earlyNCT01603355
What this trial is testing

Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Uveitis

Who this might be right for
Juvenile Idiopathic Arthritis Associated Uveitis
Eric B. Suhler 3
Large-scale testing (Phase 3)Not Yet RecruitingNCT05651880
What this trial is testing

Efficacy and Tolerance of Baricitinib, a JAK Inhibitor, in the Treatment of Refractory Non-infectious Non-anterior Uveitis

Who this might be right for
Active Non-anterior Non-infectious Uveitis
University Hospital, Rouen 33
Post-approval studies (Phase 4)UnknownNCT06085079
What this trial is testing

Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study

Who this might be right for
Uveitis, PosteriorUveitis, AnteriorUveitis, Intermediate+1 more
Massachusetts Eye Research and Surgery Institution 20
Large-scale testing (Phase 3)UnknownNCT00348153
What this trial is testing

Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial)

Who this might be right for
Uveitis
Heidelberg University 40
Not applicableStudy completedNCT00273390
What this trial is testing

A Clinical Trial of Infliximab for Uveitis

Who this might be right for
Uveitis
Oregon Health and Science University 32
Testing effectiveness (Phase 2)Study completedNCT00803816
What this trial is testing

Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A

Who this might be right for
Uveitis
Carsten Heinz 12